Cargando…
Bioengineering in the oral cavity: our experience
BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797608/ https://www.ncbi.nlm.nih.gov/pubmed/24143092 http://dx.doi.org/10.2147/IJN.S47697 |
_version_ | 1782287636789985280 |
---|---|
author | Catalfamo, L Belli, E Nava, C Mici, E Calvo, A D’Alessandro, B De Ponte, FS |
author_facet | Catalfamo, L Belli, E Nava, C Mici, E Calvo, A D’Alessandro, B De Ponte, FS |
author_sort | Catalfamo, L |
collection | PubMed |
description | BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. METHODS: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. RESULTS: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. CONCLUSION: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. |
format | Online Article Text |
id | pubmed-3797608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-37976082013-10-18 Bioengineering in the oral cavity: our experience Catalfamo, L Belli, E Nava, C Mici, E Calvo, A D’Alessandro, B De Ponte, FS Int J Nanomedicine Original Research BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. METHODS: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. RESULTS: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. CONCLUSION: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Dove Medical Press 2013 2013-10-09 /pmc/articles/PMC3797608/ /pubmed/24143092 http://dx.doi.org/10.2147/IJN.S47697 Text en © 2013 Catafalmo et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Catalfamo, L Belli, E Nava, C Mici, E Calvo, A D’Alessandro, B De Ponte, FS Bioengineering in the oral cavity: our experience |
title | Bioengineering in the oral cavity: our experience |
title_full | Bioengineering in the oral cavity: our experience |
title_fullStr | Bioengineering in the oral cavity: our experience |
title_full_unstemmed | Bioengineering in the oral cavity: our experience |
title_short | Bioengineering in the oral cavity: our experience |
title_sort | bioengineering in the oral cavity: our experience |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797608/ https://www.ncbi.nlm.nih.gov/pubmed/24143092 http://dx.doi.org/10.2147/IJN.S47697 |
work_keys_str_mv | AT catalfamol bioengineeringintheoralcavityourexperience AT bellie bioengineeringintheoralcavityourexperience AT navac bioengineeringintheoralcavityourexperience AT micie bioengineeringintheoralcavityourexperience AT calvoa bioengineeringintheoralcavityourexperience AT dalessandrob bioengineeringintheoralcavityourexperience AT depontefs bioengineeringintheoralcavityourexperience |